LUPIN

Share Price Target: Goldman Sachs maintains ‘Neutral’ rating; sees US revenue growth, EBITDA margins, strong operational outlook

Lupin Share Price Target: Global brokerage firm Goldman Sachs has reiterated its Neutral rating on pharmaceutical major Lupin Limited following a recent management interaction. The brokerage has set a target price of Rs 2,275, highlighting a stable growth outlook supported by improving profitability and expansion in key markets, particularly the United States. Lupin EBITDA margins In the management meeting, Lupin has indicated EBITDA margins of 24-25 per cent for the next financial year, which reflects improvement in operations and better product mix.